Cargando...
Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease
BACKGROUND: Orbital inflammatory diseases are a heterogenic group of conditions that often entail a difficult diagnostic process and many patients are treatment resistant. Inflammatory diseases can be visualized by Zirconium-89-labelled rituximab PET-CT ((89)Zr-rituximab PET/CT). In this study, we d...
Guardado en:
| Publicado en: | EJNMMI Res |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667535/ https://ncbi.nlm.nih.gov/pubmed/31363937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0530-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|